Should You Record Profits in Bausch Healthcare Stocks After Strong 2x Rally?
After a solid 2.4x increase from its March 2020 lows, at the current price of $31 per share, Bausch Health Companies Stock (NYSE: BHC), best known for its brand name contact lenses and generic drugs, seems to be in full swing. BHC stock fell from $13 to $31 from theRead More →